Drugs in development cost money until they make money. Leo's paying on the patent, and the patent has a finite lifespan. Between paying on the patent and paying himself and his several employees, he's eaten almost his entire budget for years, with almost nothing left over for trials (you can read the Q's for yourself and look at the balance sheets). Time is money. Leo has no money. This is a colossal part of our issue.
I feel like a broken record every time I say this.
I'm speaking generally too, not just about Brilacidin.
15yrs is on the far-end of the timeline, which is why I made the point. Total time of development on average for drugs including P3 and final approval if funded properly is closer to 10yrs. http://phrma-docs.phrma.org/sites/default/files/pdf/rd_brochure_022307.pdf Sort of highlights the need for a partner, and it's worth a read if you haven't already. It's general.
B-Covid should be progressing SIGNIFICANTLY more rapidly than it is, given the government support programmes in place and the fact that this is during a Pandemic with a global immediate need. EVERYthing is fast-tracked. Except for Brilacidin apparently.
Where the hell is the trial? Since July 2020 it's been '4Q 2020'... now '...in Jan '21' ... and now we have radio silence.